Desired mechanisms of drugs for ventricular arrhythmia: Class III antiarrhythmic agents
- 30 September 1995
- journal article
- editorial
- Published by Elsevier BV in American Heart Journal
- Vol. 130 (3), 632-640
- https://doi.org/10.1016/0002-8703(95)90382-8
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- A Comparison of Seven Antiarrhythmic Drugs in Patients with Ventricular TachyarrhythmiasThe New England Journal of Medicine, 1993
- A Comparison of Electrophysiologic Testing with Holter Monitoring to Predict Antiarrhythmic-Drug Efficacy for Ventricular TachyarrhythmiasThe New England Journal of Medicine, 1993
- Premature escape beats. A model for triggered activity in the intact heart?Circulation, 1990
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionThe New England Journal of Medicine, 1989
- An evaluation of automaticity and triggered activity in the canine heart one to four days after myocardial infarction.Circulation, 1985
- Action potential prolongation and induction of abnormal automaticity by low quinidine concentrations in canine Purkinje fibers. Relationship to potassium and cycle length.Circulation Research, 1985
- Treatment of Multifocal Atrial Tachycardia with VerapamilThe New England Journal of Medicine, 1985
- CONTROLLED TRIAL OF SOTALOL FOR ONE YEAR AFTER MYOCARDIAL INFARCTIONThe Lancet, 1982
- Cellular mechanisms for cardiac arrhythmias.Circulation Research, 1981
- Basis for Ventricular Arrhythmias Accompanying Myocardial InfarctionArchives of Internal Medicine, 1975